Investigation and Management of Hypertrophic Cardiomyopathy (HCM)

Offered By

Royal College of Physicians

Empty space, drag to resize
 
30 minutes
 
100% Online
 
No download
 
English
 
Desktop & Mobile
   
Shareable
Certificate

We've got the answers!

Purpose
Target Audience
Course Structure
Certificate
Prerequisites 
CPD

Why should I take this course?

This micro skills course from the Royal College of Physicians covers the investigation, assessment and management of hypertrophic cardiomyopathy (HCM).

Are the programs accredited for continuous professional development (CPD) or continuing medical education (CME)?

Our courses have been developed and are delivered by Talisium's global network of content providers including universities and various professional bodies whose work underpins CPD for healthcare professionals.
Certificates of completion will be available and can be downloaded once a course has been completed. These can be used as evidence of learning for training and CPD purposes. You will need to check with your governing body about CPD standards and requirements.
Unless otherwise stated, certificates issued through Talisium are not qualifications of any formal assessment.

Do I need any prior qualifications or experience?

Our courses and programs have been designed to meet the needs of a broad range of trainees and qualified healthcare professionals. For most courses, we do not ask that you hold certain qualifications or meet certain criteria.
Some courses are aligned to specialist medical curricula so there is a certain level of medical knowledge required in these cases. On the whole, however, the courses and programs are accessible to a broad audience of learners.

Validate your learning

Each participant receives a certificate upon course completion.

What you can expect

A 30 minute eLearning course containing interactive content and activities. 

This course is ideal for

All health professionals.
Overview

Here is what you will cover in
this course 

List necessary investigations in the assessment of a new patient with HCM

Assess the risk of sudden cardiac death in patients with HCM

Describe the principles of drug and device therapy in HCM

Discuss the role of genetic counselling and testing

Describe the management of left ventricular outflow tract obstruction, including pharmacological and invasive strategies

Describe the management of other complications of HCM such as atrial arrhythmias, thromboembolic events and deteriorating left ventricular function